Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak
- PMID: 32527653
- PMCID: PMC7256602
- DOI: 10.1016/j.dld.2020.05.039
Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak
Conflict of interest statement
Declaration of Competing Interest None declared.
Comment on
-
Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak.Dig Liver Dis. 2020 Jun;52(6):604-605. doi: 10.1016/j.dld.2020.04.004. Epub 2020 Apr 10. Dig Liver Dis. 2020. PMID: 32360133 Free PMC article.
References
-
- Cherradi Y. CoVID-19: a Digestive Disease. Journal of Medical and Surgical Research –JMSR- 2020;6(3):714–721. doi: 10.46327/msrjg.1.000000000000159. doi url: https://doi.org/ - DOI
-
- Sarzi-Puttini P, Marotto D, Antivalle M. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. Autoimmunity Reviews. 2020 doi: 10.1016/j.autrev.2020.102574. https://doi.org/ - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
